Meiragtx Holdings PLC (MGTX) — 10-K Filings

All 10-K filings from Meiragtx Holdings PLC. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (3)

MeiraGTx Pivots from IRDs, Focuses on Riboswitch Platform — Mar 30, 2026 Risk: high
MeiraGTx Holdings plc (MGTX) is a clinical-stage genetic medicines company with a broad pipeline, including programs for radiation-induced xerostomia, Parkinson
MeiraGTx Holdings plc Files 2024 10-K — Mar 13, 2025 Risk: medium
MeiraGTx Holdings plc filed its 2024 10-K on March 13, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, focu
MeiraGTx Holdings plc Files 2023 Annual Report on Form 10-K — Mar 15, 2024 Risk: medium
MeiraGTx Holdings plc (MGTX) filed a Annual Report (10-K) with the SEC on March 15, 2024. MeiraGTx Holdings plc reported total assets of $564,865,250 as of Dece

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX